http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1071120-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9afcd0369d6402247555a4656c0917
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
filingDate 1965-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1071120-A
titleOfInvention Pharmaceutical compositions containing substituted aralkyl amines
abstract Compounds of the formula <FORM:1071120/C2/1> wherein R is a C1 to C3 straight chain alkylene group, i.e. allyl substituted benzyl-, phenethyl-, or phenylpropyl-amines, in the latter two of which the allyl group may be in the a - or b -position, are prepared by one of the following processes: (1) a -allyl derivatives are prepared by Hoffman degradation of the amide containing one carbon atom more than the required derivative; the reaction may be effected by dissolving the amide in cold aqueous hypohalite, followed by warming the solution; (2) a -allyl derivatives are prepared by a modification of (1), wherein the reaction is effected in methanol to give the intermediate methylcarbamate derivative, which is then hydrolysed with alkali to the required a -allyl compound; (3) b -allyl derivatives are prepared by lithium aluminium hydride reduction of the corresponding amide in an organic solvent, followed by aqueous decomposition of the organo-metallic complex to give the required product. Examples are given for the following preparations: (1) a -allylphenethylamine, by solution of allylbenzylacetamide in cold aqueous sodium hypobromite, followed by warming, and subsequent ether extraction of the required product; the hydrochloride, sulphate, monohydrogen citrate, and tartrate salts of this amine are also prepared; (2) b -allylphenethylamine is prepared by reduction of a -allyl-a -phenylacetamide with LiAlH4 in tetrahydrofuran, followed by aqueous decomposition of the complex to give the required amine, which is purified by distillation; the hydrochloride salt is then prepared; (3) Allyl-benzylamine is prepared from a -allyl-a -phenylacetamide, as in (1) above, and the hydrochloride then prepared; (4) b -allyl-g -phenylpropylamine from a -allyl-b -phenyl propionamide, as in (2) above, and then converted to the hydrochloride salt; (5) a -allyl-g -phenylpropylamine is prepared by aqueous alkaline hydrolysis at elevated temperature of methyl-4-(6-phenyl-1-hexenyl carbamate, the resulting amine then being converted to the hydrochloride. The compounds are used in analgesic and tranquillizing pharmaceutical compositions (see Divisions A5-A6).ALSO:Pharmaceutical compositions, for oral, parenteral and topical application, comprise an allyl-substituted benzyl-, phenethyl-, or phenyl propyl-amine, of formula: <FORM:1071120/A5-A6/1> wherein R is a straight chain alklene group having 1, 2 or 3 carbon atoms, and the allyl group may be in the a or b position, on the alkylene chain relative to the amino group, or acceptable salts of these, with a suitable carrier. Carriers include tartaric acid; mannital; starch; sterile water; white ointment V.S.P.; syrups and elixirs, syrups containing, in water, sodium benzoate, tartaric acid, dye, flavoring and sorbitol, and elixires being a similar solution in aqueous alcohol. Talc and magnesium stearate are used as tabletting lubricants. Examples are given for the preparation of tablets and parenteral solutions of a -allyl phenethyl -amine hydrochloride, and for a syrup, an elixir, and an ointment containing the corresponding b -derivative salt. Syntheses of the active agents are also exemplified (see Division C2). The compositions are said to possess analgesic, tranquilizing, antidepressive or anorexiant properties, according to the dosage used.
priorityDate 1964-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453808416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3142088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412213222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448270076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410473046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412921807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422144127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4099777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415989201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166

Total number of triples: 51.